EMA Authorised: Truvada (emtricitabine;tenofovir disoproxil fumarate) — Gilead Sciences Ireland UC

View source ↗

Summary

The EMA has authorized Truvada (emtricitabine; tenofovir disoproxil fumarate) for use in HIV infections. MAH is Gilead Sciences Ireland UC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Gilead Sciences Ireland UC. Decision date: 16/02/2024